Drug Profile
WIN 521142
Latest Information Update: 22 Aug 1995
Price :
$50
*
At a glance
- Originator Sanofi Winthrop
- Class Non-opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 22 Aug 1995 No-Development-Reported for Pain in USA (PO)